eNews
Home page > Comments


Comments

Lilly lung cancer drug fails to meet main goal in Phase 3 study

07.09.2012. | CHICAGO (Reuters) - Drugmaker Eli Lilly and Co said on Thursday its late-stage lung cancer study failed to meet its primary goal of improved overall survival for patients with nonsquamous non-small cell lung cancer....


Оставите Ваш коментр
*Име:

Е-пошта:


*Ваш коментар:
:) :D ;) B-) :P :-o :( x-(

*Сигурносни број: